| Detected | Trial | Change |
|---|---|---|
| 2026-06-11 | NCT07227311 A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With… |
Trial sites expanded: 18 -> 27 locations |
| 2026-06-06 | NCT07213609 A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in… |
Trial sites expanded: 9 -> 13 locations |
| 2026-06-03 | NCT07227311 A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With… |
Trial sites expanded: 12 -> 18 locations |
| 2026-06-03 | NCT06847867 A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome |
Primary endpoint(s) modified |
| 2026-06-02 | NCT07569081 A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles… |
Enrollment reduced: 192 -> 136 participants |
| 2026-05-28 | NCT07218926 A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With… |
Trial sites expanded: 84 -> 121 locations |
| 2026-05-28 | NCT07286266 A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in… |
date change Primary completion pushed: 2030-07-22 -> 2030-08-21 |
| 2026-05-28 | NCT07286266 A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in… |
date change Completion pushed: 2030-07-22 -> 2030-08-21 |
| 2026-05-28 | NCT07099898 A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) |
Trial sites expanded: 114 -> 120 locations |
| 2026-05-28 | NCT07220109 A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus… |
date change Primary completion pushed: 2026-07-16 -> 2026-09-25 |
| 2026-05-28 | NCT07220109 A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus… |
date change Completion pushed: 2026-12-14 -> 2027-03-12 |
| 2026-05-28 | NCT07438782 First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of… |
Trial sites expanded: 2 -> 8 locations |
| 2026-05-28 | NCT07428759 Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT05714839 A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of… |
Trial sites expanded: 27 -> 30 locations |
| 2026-05-23 | NCT06748053 A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75… |
Trial sites reduced: 138 -> 133 locations |
| 2026-05-19 | NCT03370263 BENLYSTA® Special Drug Use Investigation |
date change Primary completion moved earlier: 2025-09-26 -> 2025-07-31 |
| 2026-05-19 | NCT03370263 BENLYSTA® Special Drug Use Investigation |
date change Completion moved earlier: 2025-09-26 -> 2025-07-31 |
| 2026-05-16 | NCT07227311 A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With… |
Trial sites expanded: 6 -> 10 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-04 | NCT07628049 A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in… | Phase 1/2 | Not Yet Recruiting |
| 2026-05-29 | NCT07614360 Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib… | Phase 2 | Not Yet Recruiting |
| 2026-05-27 | NCT07607925 A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With… | Phase 1/2 | Not Yet Recruiting |
| 2026-05-27 | NCT07609706 A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd)… | Phase 1 | Not Yet Recruiting |
| 2026-05-22 | NCT07602777 A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With… | Phase 1/2 | Not Yet Recruiting |
| 2026-05-22 | NCT07602855 A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With… | Phase 1/2 | Not Yet Recruiting |
| 2026-05-20 | NCT07600450 A Study of GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive | Phase 1 | Not Yet Recruiting |
| 2026-05-19 | NCT07596173 A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria… | Phase 3 | Not Yet Recruiting |
| 2026-05-19 | NCT07596199 A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07502560 | A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia… | Herpes Zoster | Recruiting |
| NCT06411249 | A Study Describing the Efficacy and Safety of Belimumab Administered in Adult… | Systemic Lupus Erythematosus | Recruiting |
| NCT06372496 | Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care… | Asthma | Active, Not Recruiting |
| NCT06113198 | A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup… | Meningitis, Meningococcal | Active, Not Recruiting |
| Phase 3 | |||
| NCT05855200 | Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III… | Colonic Neoplasms | Recruiting |
| NCT06572384 | A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease… | Lung Diseases, Interstitial | Recruiting |
| NCT06961214 | Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive… | Pulmonary Disease, Chronic Obstructive | Recruiting |
| NCT07221188 | A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa… | Non-alcoholic Fatty Liver Disease | Recruiting |
| NCT07221227 | A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With… | Non-alcoholic Fatty Liver Disease | Recruiting |
| NCT06679101 | A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and… | Multiple Myeloma | Recruiting |
| NCT06979323 | Depemokimab Asthma Imaging and Bronchoscopy Sub-Study | Asthma | Recruiting |
| NCT06256588 | A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally… | Neoplasms, Head and Neck | Recruiting |
| NCT07099898 | A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) | Neoplasms, Lung | Recruiting |
| NCT07218926 | A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With… | Gastrointestinal Neoplasms | Recruiting |
| NCT07220109 | A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus… | Respiratory Syncytial Virus Infections | Recruiting |
| NCT06693895 | A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy… | Chickenpox | Recruiting |
| NCT06740630 | A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When… | Chickenpox | Recruiting |
| NCT06806137 | A Study on the Immune Response and Safety of the Second Dose of an Investigational… | Chickenpox | Recruiting |
| NCT06855160 | A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a… | Chickenpox | Recruiting |
| NCT07406360 | A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps… | Measles | Not Yet Recruiting |
| NCT04167358 | Linerixibat Long-term Safety, and Tolerability Study | Cholestasis | Active, Not Recruiting |
| NCT07456033 | A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and… | Asthma | Not Yet Recruiting |
| NCT04732871 | Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory… | Respiratory Syncytial Virus Infections | Active, Not Recruiting |
| NCT04162210 | Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose… | Multiple Myeloma | Active, Not Recruiting |
| NCT04246047 | Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone… | Multiple Myeloma | Active, Not Recruiting |